<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">SS</journal-id><journal-title-group><journal-title>Surgical Science</journal-title></journal-title-group><issn pub-type="epub">2157-9407</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ss.2015.68050</article-id><article-id pub-id-type="publisher-id">SS-58249</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  A Large Animal Survival Model to Evaluate Bariatric Surgery Mechanisms
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>lad</surname><given-names>V. Simianu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jonathan</surname><given-names>G. Sham</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Andrew</surname><given-names>S. Wright</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Skye</surname><given-names>D. Stewart</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mouhamad</surname><given-names>Alloosh</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Michael</surname><given-names>Sturek</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>David</surname><given-names>E. Cummings</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>David</surname><given-names>R. Flum</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Departments of Surgery, University of Washington, Seattle, USA</addr-line></aff><aff id="aff2"><addr-line>Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, USA</addr-line></aff><aff id="aff3"><addr-line>Departments of Medicine, University of Washington, Seattle, USA</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>vsimianu@uw.edu(LVS)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>07</month><year>2015</year></pub-date><volume>06</volume><issue>08</issue><fpage>337</fpage><lpage>345</lpage><history><date date-type="received"><day>21</day>	<month>April</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>21</month>	<year>July</year>	</date><date date-type="accepted"><day>24</day>	<month>July</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: The impact of Roux-en-Y gastric bypass (RYGB) on type 2 diabetes mellitus is thought to result from upper and/or lower gut hormone alterations. Evidence supporting these mechan
  isms is incomplete, in part because of limitations in relevant bariatric-surgery animal models, specifically the lack of naturally insulin-resistant large animals. With overfeeding, Ossabaw swine develop a robust metabolic syndrome, and may be suitable for studying post-surgical physiology. Whether 
  bariatric surgery is feasible in these animals with acceptable survival is unknown. Methods: Thirty-two Ossabaws were fed a high-fat, high-cholesterol diet to induce obesity and insulin resistance. These animals were assigned to RYGB (n = 8), RYGB with vagotomy (RYGB-V, n = 5), gastrojejunostomy (GJ, n = 10), GJ with duodenal exclusion (GJD, n = 7), or sham operation (n = 2) and 
  were euthanized 60 days post-operatively. Post-operative changes in weight and food intake are re
  ported. Results: Survival to scheduled necropsy among surgical groups was 77%, living an average of 57 days post-operatively. Cardiac arrest under anesthesia occurred in 4 pigs. Greatest weight l
  oss (18.0% &#177; 6%) and food intake decrease (57.0% &#177; 20%) occurred following RYGB while animals undergoing RYGB-V showed only 6.6% &#177; 3% weight loss despite 50.8% &#177; 25% food intake decrease. GJ (12.7% &#177; 4%) and GJD (1.2% &#177; 1%) pigs gained weight, but less than sham controls (13.4%
   &#177; 10%). Conclusions: A survival model of metabolic surgical procedures is feasible, leads to significant weight loss, and provides the opportunity to evaluate new interventions and subtle variations in surgical technique (e.g. vagus nerve sparing) that may provide new mechanistic insights.
 
</p></abstract><kwd-group><kwd>Ossabaw</kwd><kwd> Bariatric Surgery</kwd><kwd> Roux-en-Y Gastric Bypass</kwd><kwd> Weight Loss</kwd><kwd> Metabolic Syndrome</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Roux-en-Y gastric bypass surgery (RYGB) promotes substantial, sustained weight loss [<xref ref-type="bibr" rid="scirp.58249-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref2">2</xref>] , and it is the most effective method to ameliorate obesity-related comorbidity including type 2 diabetes mellitus (T2DM) [<xref ref-type="bibr" rid="scirp.58249-ref3">3</xref>] -[<xref ref-type="bibr" rid="scirp.58249-ref5">5</xref>] . Because major improvements in T2DM typically occur prior and out of proportion to significant body weight loss [<xref ref-type="bibr" rid="scirp.58249-ref6">6</xref>] , the impact of RYGB on T2DM may not result from weight loss and reduced caloric intake alone. Important unanswered questions regarding the anti-diabetes effects of RYGB remain, including contributions of the proximal vs. distal intestines in T2DM remission, the reversibility of improved glycemic control with foregut exposure to food, and roles of the vagus nerve in these effects.</p><p>Over the past several years, our group has developed a porcine survival model for metabolic surgery [<xref ref-type="bibr" rid="scirp.58249-ref7">7</xref>] and more recently extended that work to address one of the major shortcomings of large animals as models for metabolic surgery. Over many generations, animal husbandry practices have limited the gene pool of large animals such that there are no natural models of “unhealthy” obesity. Farm animals rendered obese typically do not develop insulin resistance or heart disease, and consequently, large animal models of metabolic disease have been limited [<xref ref-type="bibr" rid="scirp.58249-ref8">8</xref>] . Classically, larger animals are given toxins (e.g. streptozotocin) to impair pancreatic function [<xref ref-type="bibr" rid="scirp.58249-ref9">9</xref>] , while small animal models depend on knockout or gene silencing techniques to mimic human insulin resistance.</p><p>Although a naturally occurring large animal model of diabetes does not exist, in the 1970s, on Ossabaw Island near Georgia, a colony of pigs was discovered that exhibited many features useful for the study of bariatric surgery. Abundant natural resources exist on the island only seasonally, followed by periods of food scarcity. Through generations of natural selection, surviving Ossabaw pigs gain large amounts of weight during times of plenty, allowing them to survive seasonal famines. Exhibiting “thrifty genome” characteristics when provided unrestricted access to high-calorie diets [<xref ref-type="bibr" rid="scirp.58249-ref10">10</xref>] -[<xref ref-type="bibr" rid="scirp.58249-ref12">12</xref>] , they develop obesity, insulin resistance and glucose intolerance [<xref ref-type="bibr" rid="scirp.58249-ref13">13</xref>] , dyslipidemia [<xref ref-type="bibr" rid="scirp.58249-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref15">15</xref>] , and hypertension [<xref ref-type="bibr" rid="scirp.58249-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref16">16</xref>] , which are widely accepted characteristics of metabolic syndrome (MetS) [<xref ref-type="bibr" rid="scirp.58249-ref16">16</xref>] -[<xref ref-type="bibr" rid="scirp.58249-ref18">18</xref>] .</p><p>The objective of this study was to determine the feasibility and appropriateness of bariatric surgical techniques in the Ossabaw survival model. The advantages of a large-animal model are its similarities with humans regarding techniques and anatomic features. More so than rodents, the upper GI tract is very similar in humans and pigs [<xref ref-type="bibr" rid="scirp.58249-ref19">19</xref>] , and allows application of nearly identical surgical techniques and instruments. In obese Ossabaw pigs, we describe our initial experience with long-term survival surgery including RYGB without vagotomy, RYGB with vagotomy (RYGB-V), gastrojejunostomy with duodenal exclusion (GJD, which creates a gastric- sparing bypass of the segment of proximal intestine excluded in RYGB), and gastrojejunostomy (GJ, which is identical to the latter operation with duodenal inclusion). These variations were selected to better elucidate what had been dubbed the upper and lower intestinal hypotheses for endocrine/metabolic pathways of diabetes development and resolution.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>All experimental procedures involving animals were approved by the Institutional Animal Care and Use Committee at the University of Washington (UW) with the recommendations outlined by the National Research Council and the American Veterinary Medical Association Panel on Euthanasia [<xref ref-type="bibr" rid="scirp.58249-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref21">21</xref>] .</p><sec id="s2_1"><title>2.1. Animals and Environment</title><p>Since January 2010, 32 female Ossabaw swine have entered the study protocol. Pigs were obtained from the joint Indiana University School of Medicine (IUSM) and Purdue University Facility. This study excludes 1 pig which died at IUSM before shipment. To promote weight gain and insulin resistance, animals were maintained on excess calorie high-fat, high-cholesterol diet (vide infra) for ≥180 days before arriving at UW, at age 12 - 18 months. Pigs were acclimated to the UW research facility for at least 7 days before undergoing initial vascular access catheter placement. Animals lived in a 70˚F temperature-controlled room on a 12:12-h light:dark cycle. They had free access to drinking water and were removed at least once daily for stall cleaning. Experimental pigs were fed twice daily at fixed times a customized obesogenic TestDiet<sup>&#174;</sup> containing high levels of fructose, lipids, and cholesterol, with 16.1% proteins, 43.1% lipids, and 40.8% carbohydrates (3580 kcal/meal or 7160 kcal/day).</p><p>Twenty Ossabaw were fed standard, non-fat chow (~3000 kcal/day) and served as non-surgical, lean controls. Food intake was recorded daily. Change in food intake was derived from food volume left uneaten, measured at daily feeding times, and calculated as difference from preoperative baseline.</p></sec><sec id="s2_2"><title>2.2. Intravascular Catheters</title><p>All animals were surgically implanted with vascular-access catheters to permit collection of serial blood samples and for medication administration (e.g., analgesics, antibiotics if necessary) postoperatively. Porcine animal models pose a special challenge for long-term vascular access given their size and lack of physical restraint [<xref ref-type="bibr" rid="scirp.58249-ref22">22</xref>] -[<xref ref-type="bibr" rid="scirp.58249-ref24">24</xref>] . Catheters were initially placed in the external jugular vein percutaneously, but early problems with this technique led us to switch to tunneled placement in the internal jugular vein under anesthesia. All tunneled placements used 12 Fr. Dual lumen Hickman Catheter (Bard Peripheral Vascular, Tempe, AZ) using a technique that has previously been described [<xref ref-type="bibr" rid="scirp.58249-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref26">26</xref>] . Catheter replacements were required whenever catheters malfunctioned. Early in the study period, catheters were removed at 2 weeks post-operatively and replaced close to 60 days post-operatively, prior to necropsy. Following several anesthesia-related deaths, however, pigs in the later part of the study maintained catheters throughout the entire experimental period. Catheters were flushed at least twice daily with a heparin-saline solution then locked with a solution containing vancomycin (1.0 mg/ml).</p></sec><sec id="s2_3"><title>2.3. Surgical Intervention</title><p>Pigs were randomly assigned to one of four GI operations (RYGB, RYGB-V, GJ, GJD) or a sham operation. All operations were standardized, and our pre-operative and anesthesia protocols have been previously reported [<xref ref-type="bibr" rid="scirp.58249-ref7">7</xref>] . For RYGB, a gastric pouch approximately 3 &#215; 3 cm was created. The small bowel reconstruction approximated the human RYGB with approximately ~45 cm of biliary-pancreatic-duodenal (BPD) limb. However, given recognized variation in the intestinal length of Ossabawswine [<xref ref-type="bibr" rid="scirp.58249-ref19">19</xref>] , the entire small bowel length was measured in each animal and one third of the small bowel used for an antecolic, antegastric alimentary limb. The RYGB-V is identical, but includes division of anterior and posterior vagus nerves as they cross the gastro-esophageal junction. Resection of nervous tissue was confirmed by histologic assessment. The GJ operation creates a connection between the mid-stomach and jejunum (as with RYGB procedures approximately one third of the distance on the small bowel), with full preservation of the stomach and pylorus. The GJD operation is similar to GJ, with additional division and detachment of the pylorus from the proximal duodenum, bypassing the same length of small bowel as in RYGB and RYGB-V. Sham surgery involves a full midline incision and bowel manipulation for ~130 minutes, the time of an average RYGB.</p><p>Early in the study, gastro-enteric anastomoses were performed using 4.5-mm GIA (United States Surgical, Norwalk, CT) stapler around the anvil of a 25-mm circular stapler. However, the thickened esophageal and gastric walls resulted in early anastomotic dehiscence at the esophageal-gastric junction, resulting in mediastinitis and/or peritonitis, and ultimately in untimely death in 5 animals. After these complications, we revised our protocol to hand-sewing for the gastric-jejunostomy anastomoses, and we created better practices for monitoring post-surgical outcomes to identify dehiscence within the first few post-operative days, using endoscopic exploration when animals began to deteriorate clinically. We continued to perform the side-to-side jejuno-jejunosto- my using a GIA stapler and 3-0 Maxon (United States Surgical, Norwalk, CT) reinforcement suture as we have previously described [<xref ref-type="bibr" rid="scirp.58249-ref7">7</xref>] .</p></sec><sec id="s2_4"><title>2.4. Statistical Analyses</title><p>Data analyses were descriptive rather than comparative, given the small number of animals involved. Pre-opera- tive weights are reported as means with standard deviations (SD). Weight change is reported as a percentage change (&#177;SD) using difference between pre-operative and pre-necropsy weights. Food intake change is reported as a percentage change (&#177;SD) using average daily intake before and serially after surgery. Excel (version 12.3.6, Microsoft) was used for statistical analysis.</p></sec></sec><sec id="s3"><title>3. Results</title><p>Thirty-two Ossabaw swine have been studied to date, and survival and detailed perioperative complications are reported in <xref ref-type="table" rid="table1">Table 1</xref>. Six out of 8 (75%) pigs assigned to RYGB survived to scheduled necropsy. One that died post-operatively was euthanized on POD 35 after evisceration; necropsy revealed intra-abdominal adhesions but an intact anastomosis. The other died on POD 63, with necropsy showing severe necro-hemorrhagic enteritis</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Obesogenic-diet Ossabaw survival and complications</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >All</th><th align="center" valign="middle" >Sham</th><th align="center" valign="middle" >GJ</th><th align="center" valign="middle" >GJD</th><th align="center" valign="middle" >RYGB</th><th align="center" valign="middle" >RYGB-V</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >N<sup>a</sup></td><td align="center" valign="middle"  rowspan="2"  >32</td><td align="center" valign="middle"  rowspan="2"  >2</td><td align="center" valign="middle" >10</td><td align="center" valign="middle"  rowspan="2"  >7</td><td align="center" valign="middle"  rowspan="2"  >8</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >(9 to OR)</td><td align="center" valign="middle" >(4 to OR)</td></tr><tr><td align="center" valign="middle" >N completing protocol/ N having GI surgery</td><td align="center" valign="middle" >23/30</td><td align="center" valign="middle" >1/2</td><td align="center" valign="middle" >8/9</td><td align="center" valign="middle" >6/7</td><td align="center" valign="middle" >6/8</td><td align="center" valign="middle" >1/2</td></tr><tr><td align="center" valign="middle" >(%)</td><td align="center" valign="middle" >77%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" >89%</td><td align="center" valign="middle" >86%</td><td align="center" valign="middle" >75%</td><td align="center" valign="middle" >50%</td></tr><tr><td align="center" valign="middle" >Mean Postoperative survival, days</td><td align="center" valign="middle" >56.5</td><td align="center" valign="middle" >68.5</td><td align="center" valign="middle" >59.8</td><td align="center" valign="middle" >57.8</td><td align="center" valign="middle" >61.2</td><td align="center" valign="middle" >34</td></tr><tr><td align="center" valign="middle" >Death</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Intraoperative or immediate postoperative</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >During catheter placement</td><td align="center" valign="middle"  rowspan="3"  >3</td><td align="center" valign="middle"  rowspan="3"  >1 cardiac arrest during catheter replacement, POD 75</td><td align="center" valign="middle" >1 cardiac arrest during initial catheter placement</td><td align="center" valign="middle"  rowspan="3"  ></td><td align="center" valign="middle"  rowspan="3"  ></td><td align="center" valign="middle"  rowspan="3"  ></td></tr><tr><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1 respiratory arrest during catheter replacement, POD 57</td></tr><tr><td align="center" valign="middle" >During GI surgery</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >1 cardiac arrest during initial surgery</td></tr><tr><td align="center" valign="middle" >During re-exploration</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >1 explored for leak POD7, died of intra-operative hemorrhage</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Death prior to completion of study period</td><td align="center" valign="middle"  rowspan="3"  >4</td><td align="center" valign="middle"  rowspan="3"  ></td><td align="center" valign="middle"  rowspan="3"  ></td><td align="center" valign="middle"  rowspan="3"  >1 died POD 5, pancreatitis</td><td align="center" valign="middle" >1 euthanized for eviceration on POD 35</td><td align="center" valign="middle"  rowspan="3"  >1 euthanized for prolonged difficult recovery and decreased PO intake on POD11</td></tr><tr><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1 died POD 63, presumed C. diff</td></tr></tbody></table></table-wrap><p><sup>a</sup>Pigs expiring of cardiac arrest during initial catheter placement (n = 2) not counted beyond first row as they did not undergo GI surgery.</p><p>and typhlocolitis, presumably from Clostridium difficile infection. Five pigs were assigned to RYGB-V. One had cardiac arrest during surgery and was not counted towards the overall survival. Two died before scheduled necropsy. One was re-explored on POD7 for anastomotic leak, and died during surgery. The other underwent revision of a laparotomy closure on POD2 and was subsequently euthanized on POD 11 from RYGB-V due to failure to thrive and PO intolerance. Necropsy revealed an intact but edematous gastro-jejunostomy.</p><p>Ten pigs were assigned to GJ surgery, with 8 of the 9 (89%) who underwent the operation surviving to scheduled necropsy. One pig died in the recovery phase of initial catheter placement and never underwent GJ, and was not counted towards the overall survival of the group. Another went into cardiac arrest during tunneled catheter replacement on POD 57; necropsy revealed pulmonary changes consistent with cardiac arrest. Seven pigs underwent GJD, and 6 (86%) survived to scheduled necropsy. One died on POD5; necropsy revealed pancreatitis. Two pigs underwent sham surgery, with only one surviving to scheduled necropsy. The other died on POD 75 from cardiac arrest during attempted tunneled catheter replacement.</p><p>The mean preoperative weight of high-fat-fed Ossabaws was 73.4 &#177; 8.6 kg compared to 63.2 &#177; 12.9 kg in chow-fed Ossabaws. Preoperative weights for each surgical procedure were: Sham 78.1 &#177; 15.2 kg; GJ 72.3 &#177; 8.0 kg; GJD 79.8 &#177; 8.1 kg; RYGB 68.5 &#177; 7.0 kg; and RYGB-V 70.7 &#177; 6.7 kg. Postoperative weight and food intake change, stratified by operation, are shown in <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>, respectively. Ossabaws undergoing sham</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Weight change following surgery for Obesogenic-diet Ossabaws<sup>a,b</sup>. <sup>a</sup>Mean change in weight reported as percentage (&#177;SD) change from preoperative weigh (Sham: 78.1 &#177; 15.2 kg; GJ: 72.3 &#177; 8.0 kg; GJD: 79.8 &#177;8.1 kg; RYGB: 68.5 &#177; 7.0 kg; RYGB-V: 70.7 &#177; 6.7 kg); <sup>b</sup>Only pigs surviving beyond immediate postoperative period (POD 35+) included in estimates (n<sub>Sham</sub> = 2; n<sub>GJ</sub> = 9; n<sub>GJD</sub> = 6; n<sub>RYGB</sub> = 8; n<sub>RYGB-V</sub> = 2)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-2300877x6.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Change in food intake following surgery for Obese Ossabaws<sup>a</sup>. <sup>a</sup>Only pigs surviving beyond immediate postoperative period (POD 35+) included in estimates (n<sub>Sham</sub> = 2; n<sub>GJ</sub> = 9; n<sub>GJD</sub> = 6; n<sub>RYGB</sub> = 8; n<sub>RYGB-V</sub> = 2)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-2300877x7.png"/></fig><p>operation gained 13.4% &#177; 9.5% weight and increased their food intake by 7.3% &#177; 5.2% over the experimental period. Over an equivalent period, GJ pigs gained 12.7% &#177; 4.2% weight and increased food intake by 2.1% &#177; 0.7%. Pigs in the GJD group gained 1.2% &#177; 0.5% weight but decreased their food intake by 15.6% &#177; 5.9%. Pigs in the RYGB and RYGB-V groups decreased their weight by 18.0% &#177; 6.4% and 6.6% &#177; 3.3% respectively, and decreased their food intake by 57.0% &#177; 20.2% and 50.8% &#177; 25.4%.</p></sec><sec id="s4"><title>4. Discussion</title><p>Surgical approaches to obesity consistently promote major, sustained weight loss, and improvement or remission of many, obesity-related comorbidities. This reduction in comorbidities, most notably T2DM, cannot be explained solely by the effects of weight loss and reduced caloric intake, and there are several hypotheses regarding how GI rearrangement ameliorates diabetes [<xref ref-type="bibr" rid="scirp.58249-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref27">27</xref>] . The “upper intestinal hypothesis” postulates that exclusion of the proximal small bowel from ingested nutrients exerts direct anti-diabetes effects, potentially through incompletely identified, nutrient-regulated factors or processes that influence glucose homeostasis [<xref ref-type="bibr" rid="scirp.58249-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref29">29</xref>] . The “lower intestinal hypothesis” postulates that enhanced delivery of nutrients to the distal bowel augments glucagon-like peptide-1 secretion, increasing insulin secretion [<xref ref-type="bibr" rid="scirp.58249-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref31">31</xref>] . In addition, compromised secretion of the pro-diabetic hormone ghrelin after RYGB might help improve glucose tolerance [<xref ref-type="bibr" rid="scirp.58249-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref33">33</xref>] . Unfortunately, surgical experimental GI manipulations to test these hypotheses are often not practical in humans [<xref ref-type="bibr" rid="scirp.58249-ref34">34</xref>] .</p><p>Rodents are the dominant model for metabolic surgical evaluations [<xref ref-type="bibr" rid="scirp.58249-ref19">19</xref>] , but concerns over anatomic differences and variation in physiologic responses compared with humans limit their utility in studying feasibility of surgical techniques [<xref ref-type="bibr" rid="scirp.58249-ref35">35</xref>] . Insulin resistance in obese, large animals amenable to routine biomedical study has heretofore been lacking. Although swine appear to be a more appropriate model to study bariatric surgical changes because of their anatomic and functional GI similarity to humans [<xref ref-type="bibr" rid="scirp.58249-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref37">37</xref>] , as well as their equivalent hormonal responses to starvation and feeding [<xref ref-type="bibr" rid="scirp.58249-ref38">38</xref>] -[<xref ref-type="bibr" rid="scirp.58249-ref40">40</xref>] , the lack of a swine model with insulin resistance has been problematic [<xref ref-type="bibr" rid="scirp.58249-ref8">8</xref>] .</p><p>The Ossabaw miniature swine appears to have a form of naturally occurring, polygenic insulin resistance, along with a unique propensity to obesity [<xref ref-type="bibr" rid="scirp.58249-ref10">10</xref>] -[<xref ref-type="bibr" rid="scirp.58249-ref13">13</xref>] and dyslipidemia [<xref ref-type="bibr" rid="scirp.58249-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref15">15</xref>] . Comparisons of Ossabaw swine to the well-established Yucatan swine model revealed that Ossabaws show greater propensity to obesity, especially visceral, than Yucatans on rigorously controlled experimental diets [<xref ref-type="bibr" rid="scirp.58249-ref14">14</xref>] -[<xref ref-type="bibr" rid="scirp.58249-ref17">17</xref>] . The miniature stature of Ossabaw pigs (50 - 70 kg at six months), coupled with metabolic-syndrome characteristics at this age, make them an ideal animal model for metabolic biomedical research. Having performed RYGB in other swine breeds [<xref ref-type="bibr" rid="scirp.58249-ref7">7</xref>] , we hypothesized that the Ossabaw would be a superior model for studies of metabolic surgery and glucose homeostasis. Our investigations confirm that high-fat-fed Ossabaws had higher pre-operative weights compared to lean Ossabaws. In addition, evidence of increased levels of fasting glucose, insulin, and insulin resistance in these animals and the impact of the GI surgeries on glucose homeostasis, have been separately reported by our group [<xref ref-type="bibr" rid="scirp.58249-ref41">41</xref>] .</p><p>The surgical survival model we developed is feasible and effective, but required trial and error manipulations, especially related to repeated anesthesia exposure. Although not all animals survived to necropsy, an important marker of a successful model is the ability to reproducibly perform “human-like” procedures and techniques and sustain enough animals to target survival dates. Three deaths occurred late in the study period from non-surgical causes, approximately at or beyond 60 days. We achieved 77% survival to scheduled necropsy, with intra-oper- ative cardiac arrest being the leading cause of premature death. Three of the animals died during catheter placements, with two deaths from catheter replacement prior to scheduled necropsy. Two animals required re-explo- ration, and one died of intra-operative hemorrhage. These anesthesia complications were early in the model development (first 10 cases) and prompted important changes in our protocol to minimize anesthesia exposure. Only 3 unplanned deaths occurred during the second 22 cases (86% survival).</p><p>Our GI operations were designed to clarify mechanisms involved in bariatric post-surgical changes. As expected, our sham operation served as a control and did not lead to a decrease in weight or food intake. The GJ operation creates a moderate shortcut for food to pass from the intact stomach into the proximal jejunum, equivalent to the intestinal shortcut in our porcine RYGB but without gastric restriction or proximal intestinal bypass. By expediting delivery of ingested nutrients to the distal bowel, the operation discretely engages physiologic phenomena described in the lower intestinal hypothesis, but only to a degree of RYGB. In our study, the GJ did not inhibit weight gain, and the pigs had only a slight increase in food intake. These animals could serve in future, more sophisticated studies of glucose homeostasis to explore the distal intestinal hypothesis without confounding from weight loss.</p><p>The GJD procedure creates the same shortcut from stomach to jejunum as does GJ and RYGB, but unlike GJ, it excludes proximal intestinal nutrient exposure similar to a traditional RYGB. Comparing the effects of GJD vs. GJ on glucose homeostasis will allow us to distinguish discrete consequences of phenomena described in the upper and lower intestinal hypotheses. Neither of these procedures is confounded by any added gastric alterations, nor do they cause weight loss in our pigs. We have previously reported how these operations should highlight the weight-independent effects of distal intestinal nutrient exposure vs. proximal intestinal nutrient exclusion on glucose homeostasis [<xref ref-type="bibr" rid="scirp.58249-ref41">41</xref>] , and studies describing hormonal alterations in these pigs are underway by our group.</p><p>Along with the upper and lower intestinal pathways influenced by the GJ and GJD operations, RYGB reduces gastric capacity. By comparing this operation with the other two, we can discriminate effects on glucose homeostasis that are related to gastric change and/or weight loss from those that result purely from the upper and lower intestinal hypotheses. The role of the vagus nerve in glucose homeostasis can be studied with the RYGB- V operation. The GI tract is heavily innervated by the vagus, which mediates many effects of gut peptides on satiety and glucose homeostasis [<xref ref-type="bibr" rid="scirp.58249-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.58249-ref43">43</xref>] . Hence, vagotomy might be expected to promote increased meal size and weight gain. This very preliminary data would hint that vagotomy attenuates the effects of RYGB on weight loss, without a major effect on food intake. These conclusions are limited by the small numbers and high mortality in our RYGB-V group and require further study.</p><p>There were two major learning curves with development of this model. First, we quickly learned that peripheral blood-draws were largely unsuccessful, and found placement of tunneled catheters superior. During our initial experience, we removed the tunneled catheters on POD 14 after glucose homeostasis testing and replaced them under anesthesia closer to final testing and scheduled necropsy. However, following two intra-operative arrests with catheter placements, including one in a sham surgery pig, we modified our protocol to allow tunneled catheters to remain until necropsy or catheter malfunction. Second, we learned that the thick stomach of the Ossabaw was not suitable for standard GIA staplers, and hand-sewn anastomoses became our practice.</p><p>Our model is limited by a relatively short, 60-day postoperative course, which restricts our ability to draw conclusions beyond the study time period or see complications that may develop beyond this time window. Furthermore, to date we have only studied a small number of Ossabaw in each subgroup, especially RYGB-V. Most of our deaths were early during the study period and part of our learning curve for operative technique. Lastly, while our preoperative weight, glucose, and insulin values demonstrate increased insulin resistance in high-fat- fed Ossabaws vs. lean Ossabaws, these values do not correlate perfectly with human values, and further work is needed to understand how the postoperative changes in GI physiology and glucose homeostasis relate to human counterparts.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion, the Ossabaw survival model for metabolic surgery appears to be appropriate, reproducible and should offer a novel way to evaluate the mechanism of effect of these procedures. This model is being used to evaluate the mechanism of T2DM resolution after bariatric surgery, the physiologic impact of novel surgical manipulations of the GI tract, and identification of novel targets for surgical and medical interventions.</p></sec><sec id="s6"><title>Funding Disclosures</title><p>Research reported in this publication was supported by the by the National Cancer Institute (NCI) under Award Number T32CA138312 and the National Institute of Diabetes and Digestive And Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) under Award Numbers T32DK070555 and R01DK084324. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI, NIDDK, or NIH.</p></sec><sec id="s7"><title>Author Contributions</title><p>VV Simianu, JG Sham: analysis and interpretation, data collection, writing the article, critical revision of the article SD Stewart: data collection, writing the article.</p><p>M Alloosh, M Sturek: conception and design, data collection, critical revision of the article, obtaining funding.</p><p>Wright: conception/design, data collection, writing the article, critical revision of the article.</p><p>DE Cummings, DR Flum: conception/design, analysis and interpretation, data collection, writing the article, critical revision of the article and obtaining funding.</p></sec><sec id="s8"><title>Acknowledgements</title><p>The authors would like to acknowledge Yuki Aoki<sup>1</sup> and Kelly Morrisoe<sup>1</sup> for their contributions to and coordination of perioperative care of the experimental animals. <sup>1</sup>Departments of Surgery, University of Washington, Seattle, WA, USA.</p></sec><sec id="s9"><title>Cite this paper</title><p>Vlad V.Simianu,Jonathan G.Sham,Andrew S.Wright,Skye D.Stewart,MouhamadAlloosh,MichaelSturek,David E.Cummings,David R.Flum,11, (2015) A Large Animal Survival Model to Evaluate Bariatric Surgery Mechanisms. Surgical Science,06,337-345. doi: 10.4236/ss.2015.68050</p></sec><sec id="s10"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.58249-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Sjostrom, L., Lindroos, A.K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., et al. (2004) Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery. New England Journal of Medicine, 351, 2683-2693. http://dx.doi.org/10.1056/NEJMoa035622</mixed-citation></ref><ref id="scirp.58249-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Sjostrom, L., Narbro, K., Sjostrom, C.D., Karason, K., Larsson, B., Wedel, H., et al. (2007) Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects. New England Journal of Medicine, 357, 741-752. http://dx.doi.org/10.1056/NEJMoa066254</mixed-citation></ref><ref id="scirp.58249-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M.D., Pories, W., Fahrbach, K., et al. (2004) Bariatric Surgery: A Systematic Review and Meta-Analysis. JAMA, 292, 1724-1737. http://dx.doi.org/10.1001/jama.292.14.1724</mixed-citation></ref><ref id="scirp.58249-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Pories, W.J., Swanson, M.S., MacDonald, K.G., Long, S.B., Morris, P.G., Brown, B.M., et al. (1995) Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus. Annals of Surgery, 222, 339-350. http://dx.doi.org/10.1097/00000658-199509000-00011</mixed-citation></ref><ref id="scirp.58249-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Schauer, P.R., Burguera, B., Ikramuddin, S., Cottam, D., Gourash, W., Hamad, G., et al. (2003) Effect of Laparoscopic Roux-en Y Gastric Bypass on Type 2 Diabetes Mellitus. Annals of Surgery, 238, 467-484. http://dx.doi.org/10.1097/01.sla.0000089851.41115.1b</mixed-citation></ref><ref id="scirp.58249-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Thaler, J.P. and Cummings, D.E. (2009) Minireview: Hormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery. Endocrinology, 150, 2518-2525. http://dx.doi.org/10.1210/en.2009-0367</mixed-citation></ref><ref id="scirp.58249-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Flum, D.R., Devlin, A., Wright, A.S., Figueredo, E., Alyea, E., Hanley, P.W., et al. (2007) Development of a Porcine Roux-en-Y Gastric Bypass Survival Model for the Study of Post-Surgical Physiology. Obesity Surgery, 17, 1332-1339. http://dx.doi.org/10.1007/s11695-007-9237-5</mixed-citation></ref><ref id="scirp.58249-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Varga, O., Harangi, M., Olsson, I.A. and Hansen, A.K. (2010) Contribution of Animal Models to the Understanding of the Metabolic Syndrome: A Systematic Overview. Obesity Reviews, 11, 792-807. http://dx.doi.org/10.1111/j.1467-789X.2009.00667.x</mixed-citation></ref><ref id="scirp.58249-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Otis, C.R., Wamhoff, B.R. and Sturek, M. (2003) Hyperglycemia-Induced Insulin Resistance in Diabetic Dyslipidemicyucatan Swine. Comparative Medicine, 53, 53-64.</mixed-citation></ref><ref id="scirp.58249-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Brisbin Jr., I.L. and Mayer, J.J. (2001) Problem Pigs in a Poke: A Good Pool of Data. Science, 294, 1280-1281. http://dx.doi.org/10.1126/science.294.5545.1280</mixed-citation></ref><ref id="scirp.58249-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Martin, R.J., Gobble, J.L., Hartsock, T.H., Graves, H.B. and Ziegler, J.H. (1973) Characterization of an Obese Syndrome in the Pig. Experimental Biology and Medicine, 143, 198-203. http://dx.doi.org/10.3181/00379727-143-37285</mixed-citation></ref><ref id="scirp.58249-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Martin, R.J. and Herbein, J.H. (1976) A Comparison of the Enzyme Levels and the in Vitro Utilization of Various Substrates for Lipogenesis in Pair-Fed Lean and Obese Pigs. Experimental Biology and Medicine, 151, 231-235.http://dx.doi.org/10.3181/00379727-151-39180</mixed-citation></ref><ref id="scirp.58249-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Wangsness, P.J., Martin, R.J. and Gahagan, J.H. (1977) Insulin and Growth Hormone in Lean and Obese Pigs. American Journal of Physiology, 233, E104-E108.</mixed-citation></ref><ref id="scirp.58249-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Edwards, J.M., Neeb, Z.P., Alloosh, M.A., Long, X., Bratz, I.N., Peller, C.R., et al. (2010) Exercise Training Decreases Store-Operated Ca2+ Entry Associated with Metabolic Syndrome and Coronary Atherosclerosis. Cardiovascular Research, 85, 631-640. http://dx.doi.org/10.1093/cvr/cvp308</mixed-citation></ref><ref id="scirp.58249-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Etherton, T.D. and Kris-Etherton, P.M. (1980) Characterization of Plasma Lipoproteins in Swine with Different Propensities for Obesity. Lipids, 15, 823-829. http://dx.doi.org/10.1007/BF02534372</mixed-citation></ref><ref id="scirp.58249-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Neeb, Z.P., Edwards, J.M., Alloosh, M., Long, X., Mokelke, E.A. and Sturek, M. (2010) Metabolic Syndrome and Coronary Artery Disease in Ossabaw Compared with Yucatan Swine. Comparative Medicine, 60, 300-315.</mixed-citation></ref><ref id="scirp.58249-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Dyson, M.C., Alloosh, M., Vuchetich, J.P., Mokelke, E.A. and Sturek, M. (2006) Components of Metabolic Syndrome and Coronary Artery Disease in Female Ossabaw Swine Fed Excess Atherogenic Diet. Comparative Medicine, 56, 35-45.</mixed-citation></ref><ref id="scirp.58249-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Lee, L., Alloosh, M., Saxena, R., Van Alstine, W., Watkins, B.A., Klaunig, J.E., et al. (2009) Nutritional Model of Steatohepatitis and Metabolic Syndrome in the Ossabaw Miniature Swine. Hepatology, 50, 56-67.http://dx.doi.org/10.1002/hep.22904</mixed-citation></ref><ref id="scirp.58249-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Rao, R.S., Rao, V. and Kini, S. (2010) Animal Models in Bariatric Surgery—A Review of the Surgical Techniques and Postsurgical Physiology. Obesity Surgery, 20, 1293-1305. http://dx.doi.org/10.1007/s11695-010-0135-x</mixed-citation></ref><ref id="scirp.58249-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals (2011) Guide for the Care and Use of Laboratory Animals. Eighth Edition, The National Academies Press, Washington DC.</mixed-citation></ref><ref id="scirp.58249-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">AVMA Panel on Euthanasia (2001) 2000 Report of the AVMA Panel on Euthanasia. Journal of the American Veterinary Medical Association, 218, 669-696. http://dx.doi.org/10.2460/javma.2001.218.669</mixed-citation></ref><ref id="scirp.58249-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Lombardo, C., Damiano, G., Cassata, G., Palumbo, V.D., Cacciabaudo, F., Spinelii, G., et al. (2010) Surgical Vascular Access in the Porcine Model for Long-Term Repeated Blood Sampling. Acta Bio-Medica, 81, 101-103.</mixed-citation></ref><ref id="scirp.58249-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Harris, W.H. (1974) A Technique for Chronic Venous Cannulation in Swine. Laboratory Animals, 8, 237-240.http://dx.doi.org/10.1258/002367774781005706</mixed-citation></ref><ref id="scirp.58249-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Hu, C., Cheang, A., Retnam, L. and Yap, E.H. (1993) A Simple Technique for Blood Collection in the Pig. Laboratory Animals, 27, 364-367. http://dx.doi.org/10.1258/002367793780745606</mixed-citation></ref><ref id="scirp.58249-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Swindle, M.M. (2004) Chronic Intravascular Catheterization in Swine: Peripheral Vessels. Sinclair Research Institute, Inc., Columbia.</mixed-citation></ref><ref id="scirp.58249-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Swindle, M.M. (2004) Chronic Intravascular Catheterization in Swine: General Principles. Sinclair Research Center, Inc., Columbia.</mixed-citation></ref><ref id="scirp.58249-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Rubino, F., Schauer, P.R., Kaplan, L.M. and Cummings, D.E. (2010) Metabolic Surgery to Treat Type 2 Diabetes: Clinical Outcomes and Mechanisms of Action. Annual Review of Medicine, 61, 393-411.http://dx.doi.org/10.1146/annurev.med.051308.105148</mixed-citation></ref><ref id="scirp.58249-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Cummings, D.E., Overduin, J., Foster-Schubert, K.E. and Carlson, M.J. (2007) Role of the Bypassed Proximal Intestine in the Anti-Diabetic Effects of Bariatric Surgery. Surgery for Obesity and Related Diseases, 3, 109-115.http://dx.doi.org/10.1016/j.soard.2007.02.003</mixed-citation></ref><ref id="scirp.58249-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Rubino, F., Forgione, A., Cummings, D.E., Vix, M., Gnuli, D., Mingrone, G., et al. (2006) The Mechanism of Diabetes Control after Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes. Annals of Surgery, 244, 741-749. http://dx.doi.org/10.1097/01.sla.0000224726.61448.1b</mixed-citation></ref><ref id="scirp.58249-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Cummings, D.E. (2005) Gastric Bypass and Nesidioblastosis—Too Much of a Good Thing for Islets? New England Journal of Medicine, 353, 300-302. http://dx.doi.org/10.1056/NEJMe058170</mixed-citation></ref><ref id="scirp.58249-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Thaler, J.P. and Cummings, D.E. (2008) Metabolism: Food Alert. Nature, 452, 941-942.http://dx.doi.org/10.1038/452941a</mixed-citation></ref><ref id="scirp.58249-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Cummings, D.E., Weigle, D.S., Frayo, R.S., Breen, P.A., Ma, M.K., Dellinger, E.P., et al. (2002) Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery. New England Journal of Medicine, 346, 1623-1630.http://dx.doi.org/10.1056/NEJMoa012908</mixed-citation></ref><ref id="scirp.58249-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Cummings, D.E. and Shannon, M.H. (2003) Ghrelin and Gastric Bypass: Is There a Hormonal Contribution to Surgical Weight Loss? The Journal of Clinical Endocrinology &amp; Metabolism, 88, 2999-3002.http://dx.doi.org/10.1210/jc.2003-030705</mixed-citation></ref><ref id="scirp.58249-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Courcoulas, A.P. and Flum, D.R. (2005) Filling the Gaps in Bariatric Surgical Research. Journal of the American Medical Association, 294, 1957-1960. http://dx.doi.org/10.1001/jama.294.15.1957</mixed-citation></ref><ref id="scirp.58249-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Arner, P. (2005) Resistin: Yet Another Adipokine Tells Us That Men Are Not Mice. Diabetologia, 48, 2203-2205.http://dx.doi.org/10.1007/s00125-005-1956-3</mixed-citation></ref><ref id="scirp.58249-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Cefalu, W.T. (2006) Animal Models of Type 2 Diabetes: Clinical Presentation and Pathophysiological Relevance to the Human Condition. ILAR Journal, 47, 186-198. http://dx.doi.org/10.1093/ilar.47.3.186</mixed-citation></ref><ref id="scirp.58249-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Sheikh, S.P., Holst, J.J., Orskov, C., Ekman, R. and Schwartz, T.W. (1989) Release of PYY from Pig Intestinal Mucosa; Luminal and Neural Regulation. Regulatory Peptides, 26, 253-266.http://dx.doi.org/10.1016/0167-0115(89)90193-6</mixed-citation></ref><ref id="scirp.58249-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Adrian, T.E., Bacarese-Hamilton, A.J., Smith, H.A., Chohan, P., Manolas, K.J. and Bloom, S.R. (1987) Distribution and Postprandial Release of Porcine Peptide YY. Journal of Endocrinology, 113, 11-14.http://dx.doi.org/10.1677/joe.0.1130011</mixed-citation></ref><ref id="scirp.58249-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Hayashida, T., Murakami, K., Mogi, K., Nishihara, M., Nakazato, M., Mondal, M.S., et al. (2001) Ghrelin in Domestic Animals: Distribution in Stomach and Its Possible Role. Domestic Animal Endocrinology, 21, 17-24.http://dx.doi.org/10.1016/S0739-7240(01)00104-7</mixed-citation></ref><ref id="scirp.58249-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Salfen, B.E., Carroll, J.A. and Keisler, D.H. (2003) Endocrine Responses to Short-Term Feed Deprivation in Weanling Pigs. Journal of Endocrinology, 178, 541-551. http://dx.doi.org/10.1677/joe.0.1780541</mixed-citation></ref><ref id="scirp.58249-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Sham, J.G., Simianu, V.V., Wright, A.S., Stewart, S.D., Alloosh, M., Sturek, M., Cummings, D.E. and Flum, D.R. (2014) Evaluating the Mechanisms of Improved Glucose Homeostasis after Bariatric Surgery in Ossabaw Miniature Swine. Journal of Diabetes Research, 2014, Article ID: 526972. http://dx.doi.org/10.1155/2014/526972</mixed-citation></ref><ref id="scirp.58249-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Berthoud, H.R. (2008) Vagal and Hormonal Gut-Brain Communication: From Satiation to Satisfaction. Neurogastroenterology &amp; Motility, 20, 64-72. http://dx.doi.org/10.1111/j.1365-2982.2008.01104.x</mixed-citation></ref><ref id="scirp.58249-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Cummings, D.E. and Overduin, J. (2007) Gastrointestinal Regulation of Food Intake. Journal of Clinical Investigation, 117, 13-23. http://dx.doi.org/10.1172/JCI30227</mixed-citation></ref></ref-list></back></article>